D. Sawutz

发表

In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors.

G. M. Briggs, A. Treasurywala, C. Weigelt, 1996, Biochemical pharmacology.

Characterization of bradykinin B2 receptors on human IMR-90 lung fibroblasts: stimulation of 45Ca2+ efflux by D-Phe substituted bradykinin analogues.

D. Sawutz, D. Faunce, W. T. Houck, 1992, European journal of pharmacology.

[3H] 1,3-di(2-tolyl) guanidine binds to a σ2 receptor on Jurkat cell membranes, but σ compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes

Y. Baine, D. DeHaven-Hudkins, D. Sawutz, 1996 .

High affinity binding of reovirus type 3 to cells that lack beta adrenergic receptor activity.

R. Bassel-Duby, C. Homcy, D. Sawutz, 1987, Life sciences.

2-Phenylimidazo[1,2-b]pyridazine derivatives highly active against Haemonchus contortus.

C. Francis, D. Sawutz, Abdelselam Ali, 2011, Bioorganic & medicinal chemistry letters.

2-Phenylimidazo[1,2-b]pyridazine derivatives highly active against Haemonchus contortus.

C. Francis, D. Sawutz, Abdelselam Ali, 2011, Bioorganic & medicinal chemistry letters.

Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.

K. Ogan, Y. Lotan, S. Boorjian, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacology and structure--activity relationships of the nonpeptide bradykinin receptor antagonist WIN 64338.

J. Salvino, R. Dolle, D. Sawutz, 1995, Canadian journal of physiology and pharmacology.

Synthesis, characterization, and conformational analysis of the D/L-Tic7 stereoisomers of the bradykinin receptor antagonist D-Arg0[Hyp3,Thi5,D-Tic7,Oic8]bradykinin.

J. Salvino, R. Dolle, B. Douty, 1994, Biochemistry.

Bradykinin receptor types and B2 subtypes.

Q. Nguyen, J. Salvino, D. Sawutz, 1994, Life sciences.

The effect of TNFa on bradykinin receptor binding, phosphatidylinositol turnover and cell growth in human A431 epidermoid carcinoma cells.

C. L. Johnson, D. Sawutz, C. G. Johnson, 1992, Immunopharmacology.

Structure activity relationships of non-peptide bradykinin B2 receptor antagonists

J. Salvino, R. Dolle, D. Hoyer, 1995 .

Ace inhibitors as a template for the design of bradykinin B2 receptor antagonists

R. Dolle, D. Sawutz, W. T. Houck, 1995 .

Role of bradykinin in inflammatory arthritis: identification and functional analysis of bradykinin receptors on human synovial fibroblasts.

D. Sawutz, D. Faunce, S. Singh, 1992, Immunopharmacology.

Glycosylation of the mammalian alpha 1-adrenergic receptor by complex type N-linked oligosaccharides.

R. Graham, C. Warren, S. Lanier, 1987, Molecular pharmacology.

5,7-Dimethoxy-3-(4-pyridinyl)quinoline is a potent and selective inhibitor of human vascular beta-type platelet-derived growth factor receptor tyrosine kinase.

R. Dolle, M. Bobko, D. Sawutz, 1994, Journal of medicinal chemistry.

Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor.

J. Salvino, R. Dolle, B. Douty, 1993, Journal of medicinal chemistry.

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.

G. Andriole, Y. Lotan, S. Boorjian, 2020, The Lancet. Oncology.

Coupling of the alpha 1-adrenergic receptor to a guanine nucleotide-binding regulatory protein by a discrete domain distinct from its ligand recognition site.

R. Graham, C. Homcy, D. Sawutz, 1988, Biochimica et biophysica acta.

Purification and characterization of the β2-adrenergic receptor from calf lung

R. Insoft, C. Homcy, D. Sawutz, 1986 .

AMPA (amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptors in human brain tissues.

J. Oleynek, D. Sawutz, D. Krafte, 1995, Journal of receptor and signal transduction research.

Discovery of (Z)-2-phenyl-3-(1H-pyrrol-2-yl)acrylonitrile derivatives active against Haemonchus contortus and Ctenocephalides felis (cat flea).

D. Winkler, J. Rasmussen, D. Sawutz, 2007, Bioorganic & medicinal chemistry letters.

Discovery of ectoparasiticidal hydrazonotrifluoromethanesulfonanilides.

D. Sawutz, Abdelselam Ali, S. Kyi, 2010, Bioorganic & medicinal chemistry letters.

Evidence that the sigma 1 protein of reovirus serotype 3 is a multimer

R. Bassel-Duby, M. Nibert, B. Fields, 1987, Journal of virology.

6-(4-pyridinyl)-1H-1,2,3-triazolo[4,5-d]-pyrimidin-4(5H)-one: a structurally novel competitive AMPA receptor antagonist.

A. Treasurywala, P. Pennock, E. Bacon, 1995, Journal of medicinal chemistry.

Idiotypy and the β-Adrenergic Receptor

C. Homcy, D. Sawutz, 1988 .

Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin.

F. Marceau, J. Salvino, D. Sawutz, 1994, The Journal of pharmacology and experimental therapeutics.

The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist.

J. Salvino, R. Dolle, B. Douty, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Enhanced antigen-antibody binding affinity mediated by an anti-idiotypic antibody.

C. Homcy, D. Sawutz, R. Koury, 1987, Biochemistry.

Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial

Anirban P. Mitra, G. Andriole, Y. Lotan, 2021, European Urology.

Synthesis and molecular characterization of a biotinylated analog of [Lys]bradykinin

J. Yanni, D. Sawutz, H. Wolfe, 1991, Peptides.

Effects of dimaprit on growth and differentiation of human promyelocytic cell line, HL-60.

C. L. Johnson, J. Whitsett, B. Lampkin, 1985, Life sciences.

Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells.

C. L. Johnson, J. Whitsett, D. Sawutz, 1984, The Journal of pharmacology and experimental therapeutics.

Novel inhibitors of the nuclear factor of activated T cells (NFAT)-mediated transcription of beta-galactosidase: potential immunosuppressive and antiinflammatory agents.

A. Treasurywala, C. Weigelt, Y. Baine, 1995, Journal of medicinal chemistry.

Functional characterization of novel IL-2 transcriptional inhibitors.

C. Surowy, Y. Baine, D. Sawutz, 1995, Journal of immunology.

Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.

C. Homcy, D. Sawutz, D. Sylvestre, 1985, Journal of immunology.

Alpha 1-adrenergic receptor photoaffinity labeling in intact cells.

R. Graham, D. Sawutz, L. Sena, 1987, Biochemical pharmacology.

Approach to the discovery of novel, selective inhibitors of p56lck tyrosine kinase: Identification of non‐hydroxylated chromones as p56lck inhibitors

R. Dolle, C. Faltynek, D. Sawutz, 1995 .